Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 7, 2022
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
Fri, November 4, 2022
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
James Molloy Maintained (AQST) at Strong Buy with Decreased Target to $7 on, Nov 4th, 2022
James Molloy of Alliance Global Partners, Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Decreased Target from $10 to $7 on, Nov 4th, 2022.
James has made no other calls on AQST in the last 4 months.
There are 2 other peers that have a rating on AQST. Out of the 2 peers that are also analyzing AQST, 0 agree with James's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with James
- Francois Brisebois of "Oppenheimer" Initiated at Buy and Held Target at $8.5 on, Wednesday, September 7th, 2022
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $5 on, Tuesday, September 6th, 2022
